Creso Pharma
FWB:1X8
- Creso Pharma
$0.001
Last Price
Our Investment Summary
Date of Initial Coverage
Initial Entry Price
Returns from Initial Entry
High Point
Investment Milestones
✅ Initial Investment: @2.9c
✅ Top Slice
✅ Free Carry
✅ Increased Investment: @19c
✅ Free Carry
✅ Take Profit
✅ Price increases 300% from initial entry
✅ Price increases 500% from initial entry
✅ Price increases 1000% from initial entry
✅ 12 Month Capital Gain Discount
🔲 Hold remaining Position for next 2+ years
✅ Position Exit
Our Investment Summary
Date of Initial Coverage
Initial Entry Price
Returns from Initial Entry
High Point
Investment Milestones
✅ Initial Investment: @2.9c
✅ Top Slice
✅ Free Carry
✅ Increased Investment: @19c
✅ Free Carry
✅ Take Profit
✅ Price increases 300% from initial entry
✅ Price increases 500% from initial entry
✅ Price increases 1000% from initial entry
✅ 12 Month Capital Gain Discount
🔲 Hold remaining Position for next 2+ years
✅ Position Exit
CPH is targeting US growth through M&A - Seeking a CEO
Oct 25, 2021
Next Investors
Oct 25, 2021 |
10 min
Today Creso Pharma’s (ASX:CPH) announced the acquisition of a range of CBD brand and product assets that deliver anti-inflammatory relief to professional and amateur athletes suffering from chronic muscle and joint pain.
Quick fire commentary on the six stocks making progress today
Sep 13, 2021
Next Investors
Sep 13, 2021 |
9 min
Quite a few of our portfolio companies have made announcements today - so rather than choose our favourite to focus on, we are going to provide a quick comment on each announcement
Market responding well to Psychedelics for mental health progress
Aug 17, 2021
Next Investors
Aug 17, 2021 |
7 min
CPH yesterday went on to announce the successful grant of a rare “Controlled Drugs and Substances license” licence for Haluenex in Canada, another positive step in their psychedelics story.
CPH releases material announcement
Jul 1, 2021
Next Investors
Jul 1, 2021 |
5 min
Creso Pharma Ltd (ASX:CPH | OTC:COPHF) has just confirmed two consecutive quarters of record revenue growth. CPH posted $1.71M revenue this quarter - up from $1.38M in the previous quarter - that’s 24% growth.
What We DO and DON’T like about the proposed CPH Merger
Jun 17, 2021
Next Investors
Jun 17, 2021 |
7 min
Today Creso Pharma (ASX: CPH | OTC: COPHF) announced its plans to merge with a Canadian listed psychedelics company called Red Light Holland.
The "Lesser Kown" Energy Transition Metals: Copper, Aluminium, Graphite, Helium, Rare Earths
Feb 5, 2022
Weekender
Feb 5, 2022 |
27 min
We think this investment theme is just getting started and we’re determined to repeat that success across a range of new commodities that are critical to the “energy transition”.
Our Investment Approach, Energy Cold War, Ukraine, Supply Chain Crisis
Jan 22, 2022
Weekender
Jan 22, 2022 |
17 min
With rising tensions in Eastern Europe, our macro analysis is pointing to one conclusion...the ‘Energy Transition’ is quickly turning into an ‘Energy Cold War.’
How do Fund Managers Invest in Small Cap Stocks?
Jan 14, 2022
Weekender
Jan 14, 2022 |
17 min
We maintain a diversified portfolio of over 20 positions (currently ~40 across all portfolios) in the hope that 2 or 3 will achieve an outsized return and outweigh the companies that may fail.
New COVID strain, Santa Rally, Market Thoughts
Nov 27, 2021
Weekender
Nov 27, 2021 |
16 min
It seems Black Friday sales were not exclusive to just shopping centres as the entire stock market took a beating yesterday - and when that happens small caps suffer too.
Australia bets big on Hydrogen at COP26, investment in companies that solve problems
Nov 20, 2021
Weekender
Nov 20, 2021 |
10 min
If you’ve followed our investments closely - or even if you are new, we think you’ll find that we have positions across the macro themes; emissions, healthcare, inflation
